Etanercept Biosimilar Safe and Effectively Treats RA - DocWire News
Etanercept Biosimilar Safe and Effectively Treats RA DocWire News
The results of a recent trial found that patients with moderate-to-severe rheumatoid arthritis (RA) who switched from etanercept (ETN) to biosimilar sandoz.
Comments
Post a Comment